Pulmonary Fibrosis
The DOI matches its Crossref record, with a small difference in title or year; 37 of the 38 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Substantial challenges remain in our understanding of fibrotic lung diseases. Nowhere is this more true than in the elucidation and verification of the pathogenetic basis upon which they develop. Scientific progress, most recently in the field of experimental therapy, has relied closely on interpreting data derived from animal modeling. Such models are used to identify the cellular interactions and molecular pathways involved in lung tissue repair and fibrosis. Over the coming years, the significance of new discoveries will continue to be evaluated using the in vivo analysis of animal models substituting for patients with actual pulmonary fibrosis. The commonest strategy to induce experimental pulmonary fibrosis is by directly administering a profibrotic agent to either wild-type animals or those that bear a specific genetic modification. The creation of new models has been greatly enhanced by the availability of stem cell lines and methods for introducing genetic mutations into these cells. Despite an increasing choice of models, there are still good reasons to continue adapting and using one of its earliest examples, the bleomycin model, in post-genomic pulmonary fibrosis research. A brief review of the exacting requirements of such research will place the strengths of this particular model in perspective.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pulmonary fibrosis is also included in the host response to reverse the loss of essential metal after its sequestration by asbestos (Figure 3 and Figure 4) [64].”
From Asbestos and Iron (2023) · cites this paper as [64]
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Self-citationLee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Resolution of Lung Inflammation by CD44
Teder, P., Vandivier, R. W., Jiang, D., Liang, J., Cohn, L., Puré, E., Henson, P. M., & Noble, P. W. (2002) · Science · doi:10.1126/science.1069659 · Cited by 677
Selman, M., Ruiz, V., Cabrera, S., Segura, L., Ramírez, R., Barrios, R., & Pardo, A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l562 · Cited by 425
Kaminski, N., Allard, J. D., Pittet, J. F., Zuo, F., Griffiths, M. J. D., Morris, D., Huang, X., Sheppard, D., & Heller, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1778 · Cited by 417
Giri, S. N., Hyde, D. M., & Hollinger, M. A. (1993) · Thorax · doi:10.1136/thx.48.10.959 · Cited by 402
Research works printed but not linked: 5
- 1993, Monogr Pathol, 36, 78
- 2002, Respir Res, 3, 1
- 1978, Am Rev Respir Dis, 117, 289
- 1996, Lab Invest, 74, 12
- 1993, Thorax, 48, 956
Cited by
Items 301–316 of 316
Immunité innée et inflammasome : rôle des signaux de dangers endogènes
Riteau, N. (2011) · theses.fr (ABES) · doi:10.70675/c1f41e57z7b3cz417czae4ez9c5a688e9661
Bantsimba-Malanda, C. (2009) · theses.fr (ABES) · doi:10.70675/b5564f90zc43cz4a7az9e2dzf77a62264eff
Hénaoui, I. S. (2013) · theses.fr (ABES) · doi:10.70675/9b5eefb2zda67z4abezb5a7z715be0b8c813
Rôle de la voie hedgehog dans la fibrose pulmonaire idiopathique
Moshai, E. F. (2013) · theses.fr (ABES) · doi:10.70675/b550340ez33a1z43b7zb4eez8c2cfde874df
Implication de FGF9 et de FGF19 dans la fibrose pulmonaire idiopathique
Justet, A. (2020) · theses.fr (ABES) · doi:10.70675/6e72f095z0cb6z4dd3zb204z88d1b08b9910
Rôle des plaquettes dans la fibrose pulmonaire et l'anévrisme intracrânien
Martos, R. (2022) · theses.fr (ABES) · doi:10.70675/75ba5efez9d6ez41c2zbeddz24cc271f253e
Rôle des FGFs endocrines et leurs récepteurs au cours de la fibrose pulmonaire idiopathique
Ghanem, M. (2023) · theses.fr (ABES) · doi:10.70675/fd0d64f8zacf4z4856z9b1az66d4df37a332
Lei, Z., Chen, C., Shi, J., Shen, Z., Ling, P., Wei, C., Zhu, B., Kong, W., Zhang, Z., Chen, T., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103309
Nishioka, T., Sakabe, T., Kitabatake, M., Ouji-Sageshima, N., Hara, A., Sato, I., Fujioka, N., Furukawa, R., Kasamatsu-Nishimura, T., Hontsu, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-57394-5
Li, C., Wang, L., Wang, F., Wang, L., Xu, L. H., Lyu, W., Shan, K., Li, J., Zhou, H., Rong, F., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03921-0
Wise, A. L. (2008) · DukeSpace (Duke University)
Fibrocytes in Chronic Lung Disease
Maharaj, S. S. (2014) · MacSphere (McMaster University) · doi:10.71548/15551
Metadata
- Authors
- Chua, F., Gauldie, J., & Laurent, G. J.
- Affiliations
- The Royal Free Hospital (GB)
- ORCID
- Chua, Felix
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07-01
- Volume
- 33
- Issue
- 1
- Pages
- 9-13
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2051772841
- Cited by
- 305
- References
- 36
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 10 · 2023: 24 · 2022: 18 · 2021: 7 · 2020: 12 · 2019: 7 · 2018: 13 · 2017: 17 · 2016: 7 · 2015: 12 · 2014: 19 · 2013: 19 · 2012: 12
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- pulmonary fibrosis, bleomycin-induced fibrosis, experimental fibrosis, genetic modification, stem cell lines, lung repair, fibrosis pathogenesis, postgenomics
- MeSH terms
- Animals, Antimetabolites, Antineoplastic, Bleomycin, Disease Models, Animal, Extracellular Matrix, Fibrosis, Humans, Lung, Lung Diseases, Models, Biological, Mutation, Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.